The Omega-3 Acid Ethyl Esters Capsul, cataloged under National Stock Number 6505-01-727-4835, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Avkare Llc. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-727-4835 |
| Primary Part Number | NDC42291-0657-12 |
| Item Name | Omega-3 Acid Ethyl Esters Capsul |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Avkare Llc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC42291-0657-12 | Dms Pharmaceutical Group Inc (USA) |
| NDC42291-0657-12 PRIMARY | Avkare Llc (USA) |
| NDC42291-0657-12 | Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office (USA) |
| Reference | Meaning |
|---|---|
| 1680405 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM251270 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-727-4835 is a Omega-3 Acid Ethyl Esters Capsul, manufactured by Avkare Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-727-4835 has 3 manufacturer part numbers on file: NDC42291-0657-12 (Dms Pharmaceutical Group Inc), NDC42291-0657-12 (Avkare Llc), NDC42291-0657-12 (Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office).
Key specifications for NDC42291-0657-12: Special Features: INDICATIONS AND USAGE: ARE A COMBINATION OF ETHYL ESTERS OF OMEGA 3 FATTY ACIDS, PRINCIPALLY EICOSAPENTAENOIC ACID (EPA) AND DOCOSAHEXAENOIC ACID (DHA), INDICATED AS AN ADJUNCT TO DIET TO REDUCE TRIGLYCERIDE (TG) LEVELS IN ADULT PATIENTS WITH SEVERE (500 MG/DL) HYPERTRIGLYCERIDEMIA; PATIENTS SHOULD BE ADVISED TO SWALLOW OMEGA-3-ACID ETHYL ESTERS CAPSULES WHOLE. DO NOT BREAK OPEN, CRUSH, DISSOLVE, OR CHEW OMEGA-3-ACID ETHYL ESTERS CAPSULES; DOSAGE FORMS AND STRENGTHS: 1 GRAM TRANSPARENT SOFT-GELATIN CAPSULES. ACTIVE INGREDIENT: MEGA-3-ACID ETHYL ESTERS (UNII: D87YGH4Z0Q) (OMEGA-3 FATTY ACIDS -UNII:71M78END5S). BOTTLE OF 120 CAPSULES; STORE IN TIGHT, LIGHT-RESISTANT CONTAINERS AT 25 C (77 F); EXCURSIONS PERMITTED TO 15 TO 30 C (59 TO 86 F) (SEE USP CONTROLLLED ROOM TEMPERATURE). PROTECT FROM LIGHT. DO NOT FREEZE. KEEP OUT OF REACH OF CHILDREN. G; Part Name Assigned by Controlling Agency: OMEGA-3 ACID ETHYL ESTERS CAPSULE, LIQUID FILLED, 1 GM, 120S. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.